Objective: Gamma Knife surgery has become an accepted treatment for small to medium‑size vestibular schwannoma with a high rate of tumor control and good clinical outcome. When GKS treatment fails to stop tumor growth, GKS retreatment can be proposed in selected cases. This retrospective study examines the clinical and tumor control outcome after the second GKS retreatment for the same vestibular schwannomas.
Methods: A total of 14 consecutive vestibular schwannomas patients retreated with 2nd GKS were included: The median time interval between GKS treatments was 44 months, and the median follow‑up duration after last GKS retreatment was 60 months. The median marginal dose used for the first and second treatments was 12 Gy. The median tumor volume at the initial GKS was 2.4cc (range 0.27-3.8) and was 3.8cc (range 1.21-7.6) at the GKS retreatment.
Results: At the last follow‑up, 93% (13 patients) had tumor growth control, decreased in 4, remained unchanged in 9, and increased tumor size in one patient. New facial or severe trigeminal palsy did not occur after the second GKS retreatment. The hearing was not preserved except in one patient post-GKS retreatment.
Conclusions: GKS retreatment after the failure of initial GKS to control vestibular schwannomas growth appears to be an effective strategy and can be proposed as an alternative to microsurgery when the tumor volume remains within the usual radiosurgical range.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clineuro.2020.106171 | DOI Listing |
J Clin Med
November 2024
Department of Radiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
Acta Neurochir (Wien)
September 2024
Department of Neurosurgery, NTT Medical Center Tokyo, Shinagawa-Ku, Tokyo, Japan.
Cureus
September 2023
Department of Dentistry, K. J. Somaiya Medical College, Mumbai, IND.
Stereotactic radiosurgery (SRS), also known as gamma knife surgery (GKS), is a noninvasive procedure for treating tic douloureux (TD) or trigeminal neuralgia (TN). Due to a lack of sufficient evidence regarding the indication of SRS for the treatment of recurrent TD, the present scoping review was conducted to assess the effectiveness of repeated SRS procedures for managing recurrent TD. The literature search was performed from January 2012 to December 2022 on the PubMed, Scopus, and Web of Science databases.
View Article and Find Full Text PDFNeurosurg Rev
February 2022
Department of Functional Neurosurgery and Gamma Knife Radiosurgery, Ruber Internacional Hospital, C/ La Masó, 38, CP 28034, Madrid, Spain.
We present our experience with Gamma Knife surgery (GKS) and refractory glossopharyngeal neuralgia (GPN), analyzing its usefulness and safety in patients with or without previous surgeries, another concomitant neuralgia, or retreats. In addition, we study some factors that could condition the outcome of this technique. According to our review, our follow-up is the longest in the literature.
View Article and Find Full Text PDFClin Neurol Neurosurg
November 2020
Department of Neurosurgery and Gamma Knife Center, International Medical Center (IMC), 42km. Ismailia Desert Road, Cairo, Egypt.
Objective: Gamma Knife surgery has become an accepted treatment for small to medium‑size vestibular schwannoma with a high rate of tumor control and good clinical outcome. When GKS treatment fails to stop tumor growth, GKS retreatment can be proposed in selected cases. This retrospective study examines the clinical and tumor control outcome after the second GKS retreatment for the same vestibular schwannomas.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!